Evidence map›Paper›PMID 30541879›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Extent of MHC Clustering Regulates Selectivity and Effectiveness of T Cell Responses.

Nadia Anikeeva, Nicholas O Fischer, Craig D Blanchette, Yuri Sykulev

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Factors contributing to the potency of CD8Trends in immunology · 2023
    Review
  5. Review
  6. Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nadia AnikeevaDepartment of Microbiology and Immunology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107; and.
Nicholas O FischerBiosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94551.
Craig D BlanchetteBiosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94551.
Yuri SykulevDepartment of Microbiology and Immunology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107; and Yuri.Sykulev@Jefferson.edu.ORCID 0000-0002-9685-0223
Lawrence Livermore National Laboratory · USThomas Jefferson University · US

Funding

Defining optimal TCR-pMHC interactions: implication for designing new T-cell based therapeutics to treat viral infections and cancerR01CA217714 · NCI · THOMAS JEFFERSON UNIVERSITY · PI SYKULEV, YURI · 2017 to 2019
$468k
Exploiting an artificial APC to induce different T cell subsetsR21AI113819 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SYKULEV, YURI · 2015 to 2016
$468k
NCI NIH HHS R01 CA217714NIAID NIH HHS R21 AI113819
6 · The paper itself

Abstract

MHC proteins that present peptide ligands for recognition by TCR form nanoscale clusters on the cell membrane of APCs. How the extent of MHC clustering controls productive TCR engagement and TCR-mediated signaling has not been systematically studied. To evaluate the role of MHC clustering, we exploited nanoscale discoidal membrane mimetics (nanolipoprotein particles) to capture and present peptide-MHC (pMHC) ligands at various densities. We examined the binding of these model membrane clusters to the surface of live human CD8

Indexed as

Signal TransductionBinding SitesBiomimeticsCD8-Positive T-LymphocytesHistocompatibility Antigens Class IHumansKineticsLymphocyte ActivationPeptidesProtein BindingReceptors, Antigen, T-CellHistocompatibility Antigens Class IPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID30541879
PMCPMC6362847
OpenAlexW2905330124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.